Diabetes
Study Compares PDR, DME Risk Between Two Popular Diabetes Drugs
Patients taking GLP-1 agonists had a higher rate of progression to proliferative retinopathy and new-onset macular edema than those on SGLT-2 inhibitors.
04/19/2024
Glucose Control, Renal Function Help Predict Anti-VEGF Treatment Response in DME
Patients with low glomerular filtration rates and high glycated hemoglobin levels fared worse in this study, highlighting the need for continuous monitoring of systemic health.
04/17/2024
Academy of Ophthalmology Endorses Teleretinal Screening for Diabetic Retinopathy
While this modality was not as robust in detecting DME, studies show it is both accurate and cost-effective for DR.
04/16/2024
Diabetes Patients Experience Choroidal Microvascular Alterations Before DR
This was observed in early cases of the disease without associated retinopathy.
04/16/2024
Severity Levels of Carotid Artery Stenosis Impact Diabetic Retinopathy
Clinicians should be mindful of possible atherosclerotic changes in patients with PDR, study argues.
04/15/2024
Thyroid Function-related Hormones a Risk Factor for DR
Study shows that alterations in patients with normal thyroid function may affect glucose and lipid metabolism, increasing the risk of DR.
04/04/2024
Certain Lipid Abnormalities May Reduce DR Risk in Type 2 Diabetes
Though dyslipidemia is associated with this complication, new research shows that reduced HDL levels and elevated cholesterol and triglycerides may actually have a protective effect.
03/29/2024
Choriocapillaris May Be Earliest Affected, Most Vulnerable Region in DR
Study shows impairment here is associated with HbA1c levels and can precede clinical manifestations.
03/26/2024
Diabetic Eye Disease Research: Many Dollars, Few Drugs
Nearly $1 billion was spent from 2012 to 2021—practically all by the NIH—and the number of published papers on the topic increased 3.5-fold, but new drug approvals were scant.
03/21/2024
Study Supports Bevacizumab as First-line DME Therapy
This affordable anti-VEGF conferred real-world visual gains and cost savings with fewer injections over time.
03/14/2024
Upcoming Events
May 2, 2024
Rethinking Dry Eye Disease: A Contemporary Approach to a Complex Condition
Location: Virtual
Presenters: Kamran Riaz, MD, and Melissa Barnett, OD
Webinar: 7:00pm ET
Sponsored by Bausch + Lomb
May 17-19, 2024
June 4, 2024
Rethinking Dry Eye Disease: A Contemporary Approach to a Complex Condition
Location: Virtual
Presenters: Karl G. Stonecipher, MD, and Jessica Steen, OD
Webinar: 8:00pm ET
Sponsored by Bausch + Lomb
